4 stories mentioning EVHUpdated 3d ago
Every FINWIRES story that references EVH, newest first.
Evolent Health (EVH) shares rose 3% in Tuesday trading after Citigroup upgraded the stock to buy from neutral and adjusted its price target to $6 from $6.75.Trading volume stood at 2.6 million shares, compared with a daily average of 3 million.Price: $4.05, Change: $+0.12, Percent Change: +3.05%
Evolent Health (EVH) has an average rating of buy and mean price target of $5.96, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Evolent Health (EVH) has an average rating of buy and mean price target of $5.96, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Evolent Health (EVH) has an average rating of buy and mean price target of $5.88, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
